Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice.

Nuclear Medicine and Biology
Sadaf AghevlianKatherine W Ferrara

Abstract

A novel [64Cu]Cu-NOTA-aCD40 immunoPET tracer was developed to image a CD40+ pancreatic tumor model in C57BL/6 mice and to study the biodistribution profile of the agonist CD40 (aCD40) monoclonal antibody (mAb) alone or combined with other mAbs. Copper-64 ([64Cu]Cu) labeled NOTA-aCD40 and NOTA-IgG (10 μg; 7 MBq) were injected intravenously into C57BL/6 mice with subcutaneous mT4 tumors to assess specificity 48 h post injection (p.i.) through positron emission tomography/computed tomography (PET/CT) imaging and biodistribution studies (n = 5). [64Cu]Cu-NOTA-aCD40 was injected alone or simultaneously in combination with a therapeutic mass of cold aCD40 (100 μg), aPD-1 (200 μg) and aCTLA-4 (200 μg) mAbs. A group of mice with or without tumor received the second round of injections 1 or 3 weeks apart, respectively. PET/CT imaging and biodistribution studies were performed at 48 h p.i. The organ dose for [64Cu]Cu was estimated based on biodistribution studies with 2 μg [64Cu]Cu-NOTA-aCD40 (corresponds to 5 mg patient dose) in non-tumor bearing mice. [64Cu]Cu-NOTA-aCD40 accumulation was 2.3- and 7.8-fold higher than [64Cu]Cu-NOTA-IgG in tumors and spleen, respectively, indicating the specificity of aCD40 mAb in a mouse pancreatic tumo...Continue Reading

References

Mar 10, 2004·The Journal of Experimental Medicine·Cory L AhonenRoss M Kedl
Dec 14, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Kaijun ZhangMathew L Thakur
May 12, 2009·Immunological Reviews·Raul ElguetaRandolph J Noelle
Oct 20, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Pontus K E BörjessonRonald Boellaard
Jul 28, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jason P HollandJason S Lewis
Jun 30, 2012·Nuclear Medicine and Biology·Ravindra A De SilvaBuck E Rogers
Jan 6, 2015·Cell·Sylvia F BojDavid A Tuveson
Mar 18, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laetitia E LambertsElisabeth G E de Vries
Jun 14, 2016·Cell Reports·Katelyn T Byrne, Robert H Vonderheide
Dec 9, 2016·Expert Review of Anticancer Therapy·Gregory L BeattyKristen B Long
May 26, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Emma ErikssonAngelica Loskog
Sep 21, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kirstin A ZettlitzAnna M Wu
Feb 14, 2018·The Journal of Experimental Medicine·Curtis J PerrySusan M Kaech
Feb 14, 2018·The Journal of Experimental Medicine·Sabine HovesCarola H Ries
Apr 11, 2018·International Immunopharmacology·Veronika CaisováJan Ženka
Jun 16, 2018·Nature Reviews. Drug Discovery·Patrick A MayesAxel Hoos
Oct 10, 2018·Proceedings of the National Academy of Sciences of the United States of America·David A KnorrJeffrey V Ravetch
Apr 18, 2019·Journal for Immunotherapy of Cancer·Jasmine DavdaEugenia Kraynov
May 10, 2019·Scandinavian Journal of Immunology·Luis SarmientoCorrado M Cilio
Aug 14, 2019·Human Vaccines & Immunotherapeutics·David M RichardsChristian Merz
Aug 15, 2019·Annual Review of Medicine·Robert H Vonderheide

❮ Previous
Next ❯

Related Concepts

Related Feeds